Related Experiment Video
Updated: Aug 30, 2025

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Interlaboratory comparison study of immunosuppressant analysis using a fully automated LC-MS/MS system
Noël Zahr1, Helen Duce2, Joanne Duffy2
1Pharmacokinetics and Therapeutic Drug Monitoring Unit, Department of Pharmacology and Clinical Investigation Center (CIC-1901), AP-HP, Sorbonne Université, Paris, France.
Automated liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers harmonized immunosuppressant quantification in whole blood. This study validates a new automated system, showing excellent interlaboratory agreement and minimal bias for tacrolimus and other immunosuppressants.
Area of Science:
- Clinical Chemistry
- Analytical Chemistry
- Pharmacology
Background:
- Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is recommended for immunosuppressant quantification but limited by method complexity and lack of harmonization.
- Immunoassays are widely used despite LC-MS/MS superiority due to practical challenges.
- A fully automated LC-MS/MS system (Cascadion™) aims to simplify clinical application.
Purpose of the Study:
- To evaluate the interlaboratory comparability of immunosuppressant assays using the automated Cascadion™ LC-MS/MS system.
- To assess the impact of sample handling procedures (freezing/thawing, primary vs. secondary tubes) on assay results.
Main Methods:
- Three European centers performed interlaboratory comparisons on 1097 whole blood samples.
- Samples were shared between sites to assess method agreement.
- Experiments included freeze-thaw stability and primary vs. secondary tube analysis.
Main Results:
- Excellent correlation coefficients (0.990-0.993) were observed for cyclosporine A, everolimus, sirolimus, and tacrolimus.
- Minimal average bias was found for tacrolimus in fresh vs. frozen samples (0.36%) and primary vs. secondary tubes (1.14%).
Conclusions:
- The automated Cascadion™ platform achieves a high level of result harmonization for LC-MS/MS immunosuppressant analysis.
- This system facilitates the routine clinical use of LC-MS/MS for accurate immunosuppressant monitoring.
More Related Videos
07:34Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
11:00Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
Published on: May 20, 2013